| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/24/1998 | WO1998041562A1 Non-antigenic branched polymer conjugates |
| 09/24/1998 | WO1998041238A2 Methods and kits for treating and diagnosing leiomyomas |
| 09/24/1998 | WO1998041236A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance |
| 09/24/1998 | WO1998041232A2 Compositions for modulating responsiveness to corticosteroids |
| 09/24/1998 | WO1998041226A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 09/24/1998 | WO1998041220A1 Mononuclear phagocytes and their use to promote axonal regeneration |
| 09/24/1998 | WO1998041216A1 Composition for prevention of hepatic steatosis |
| 09/24/1998 | WO1998041213A1 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof |
| 09/24/1998 | WO1998041207A1 Administration of an injectable antibiotic in the ear of an animal |
| 09/24/1998 | CA2644454A1 Death domain containing receptor 5 |
| 09/24/1998 | CA2284039A1 Methods and kits for treating and diagnosing leiomyomas |
| 09/24/1998 | CA2283891A1 Mononuclear phagocytes and their use to promote axonal regeneration |
| 09/24/1998 | CA2283690A1 Human tumor suppressor |
| 09/24/1998 | CA2283688A1 Serine/threonine protein kinase |
| 09/24/1998 | CA2283674A1 Human pancreatitis-associated protein, pap-2 |
| 09/24/1998 | CA2282845A1 Methods and compositions for modulating responsiveness to corticosteroids |
| 09/23/1998 | EP0866127A2 HE8AN36, a steroid hormone receptor homolog |
| 09/23/1998 | EP0866124A2 Composition containing a compound modifying directly or indirectly the activity of endogenous T1-M protein |
| 09/23/1998 | EP0865421A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 09/23/1998 | EP0865298A1 Drug therapy |
| 09/23/1998 | EP0865293A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/23/1998 | EP0865290A1 Pharmaceutical compositions for oral use including an nsaid and ceramides |
| 09/23/1998 | EP0865275A2 Graft survival prolongation with porphyrins |
| 09/23/1998 | EP0865274A2 Surface-stabilised pharmaceutical preparation for application on the skin |
| 09/23/1998 | EP0764169B1 Drug salts |
| 09/23/1998 | CN1194009A 结肠特异性基因及蛋白质 Colon-specific genes and proteins |
| 09/23/1998 | CN1193980A G-protein receptor HTNAD 29 |
| 09/23/1998 | CN1193912A Use of L-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral |
| 09/23/1998 | CN1193911A Use of basic amino acids and derivatives for lowering ceramide levels |
| 09/23/1998 | CN1193910A Use of alicyclic diamines as immunomodulators |
| 09/23/1998 | CN1193907A Preparation and methods for the treatment of T cell mediated diseases |
| 09/23/1998 | CN1193894A Two-stage preparation |
| 09/23/1998 | CN1193536A Method for preparing cosmetics and medicines concerned with blood types |
| 09/22/1998 | US5811553 Quinoline derivatives(2) |
| 09/22/1998 | US5811535 Human cartilege gp39-like gene |
| 09/22/1998 | US5811520 Human phospholipase inhibitor protein |
| 09/22/1998 | US5811451 Antiinflammatory agents; infections; osteoporosis; autoimmune diseases; human and veterinary medicine; cattle, dogs, horses; gastrointestinal and respiratory dsystem disorders; glandular disorders |
| 09/22/1998 | US5811449 Administering a suppressor pyrrolidine dithiocarbamate to prevent the oxidation of a polyunsaturated fatty acid |
| 09/22/1998 | US5811446 Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| 09/22/1998 | US5811423 Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 09/22/1998 | US5811416 Administering to treat disorders such as dysmenorrhea, preterm labor, preeclampsia, or fetal growth retardation; also hormone replacement therapy, hypertension |
| 09/22/1998 | US5811410 Nonsteroidal antiinflammatory drugs |
| 09/22/1998 | US5811100 Hyaluronidase covalently coupled to immunostimulating carrier |
| 09/22/1998 | US5811097 Decreasing growth of tumor cells by administering blocking agent which binds to extracellular domain of cytotoxic t-lymphocyte-associated molecule and inhibits signaling |
| 09/22/1998 | US5811088 Antiinfective compounds and methods of use |
| 09/22/1998 | US5811005 Apparatus for intravenous administration of solutions of cell-free hemoglobin including a nitroxide bound to a matrix |
| 09/22/1998 | US5810888 Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery |
| 09/22/1998 | CA2138366C Methods for the treatment of arthritis using phosphonates and nsaids |
| 09/21/1998 | CA2232637A1 Composition containing a compound which directly or indirectly modifies the activity of endogenous t1-m protein |
| 09/17/1998 | WO1998040738A1 Prostate specific antigen substrates |
| 09/17/1998 | WO1998040488A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | WO1998040482A1 Growth factor receptor binding protein |
| 09/17/1998 | WO1998040375A2 COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS |
| 09/17/1998 | WO1998040102A1 Cytoprotective agents comprising monoamine oxidase inhibitors |
| 09/17/1998 | WO1998040101A1 Drugs containing enzyme inhibitors as the active ingredient |
| 09/17/1998 | WO1998040093A1 Method of antagonizing the human src sh2 domain |
| 09/17/1998 | WO1998040088A1 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 09/17/1998 | WO1998040078A1 Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives |
| 09/17/1998 | WO1998040071A1 Identification of agents for use in the treatment of alzheimer's disease |
| 09/17/1998 | WO1998040070A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 09/17/1998 | WO1998040067A1 Use of benzofuran derivatives for reducing death rate after myocardial infarction |
| 09/17/1998 | WO1998040065A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | WO1998040057A1 Spermicide |
| 09/17/1998 | WO1998040056A2 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 09/17/1998 | WO1998040055A2 Anti-epileptogenic agents |
| 09/17/1998 | WO1998040052A1 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/17/1998 | WO1998039967A1 A method for treating or preventing alzheimer's disease |
| 09/17/1998 | WO1998031394A3 Tissue factor methods and compositions for coagulation and tumor treatment |
| 09/17/1998 | WO1998007850A3 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 09/17/1998 | CA2323889A1 A method for treating or preventing alzheimer's disease |
| 09/17/1998 | CA2285446A1 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | CA2284137A1 Prostate specific antigen substrates |
| 09/17/1998 | CA2284094A1 Drugs containing enzyme inhibitors as the active ingredient |
| 09/17/1998 | CA2284001A1 Cytoprotective agents comprising monoamine oxidase inhibitors |
| 09/17/1998 | CA2283575A1 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and hmg co-a reductase inhibitors |
| 09/17/1998 | CA2283485A1 Spermicide |
| 09/17/1998 | CA2283472A1 Method of antagonizing the human src sh2 domain |
| 09/17/1998 | CA2283313A1 Anti-epileptogenic agents |
| 09/17/1998 | CA2283296A1 Growth factor receptor binding protein |
| 09/17/1998 | CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | CA2232751A1 Novel compounds |
| 09/16/1998 | EP0863992A1 Product and process to regulate actin polymerization |
| 09/16/1998 | EP0863899A1 Pyridopyrimidines |
| 09/16/1998 | EP0863770A1 Contrast medium and its use |
| 09/16/1998 | EP0863760A1 Use of antimineralocorticoid compounds against drug withdrawal syndrome |
| 09/16/1998 | EP0863754A1 Hydrolysis-optimized lipid emulsions and use thereof |
| 09/16/1998 | EP0863741A2 Reduction of hair growth |
| 09/16/1998 | EP0863740A1 Reduction of hair growth |
| 09/16/1998 | EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof |
| 09/16/1998 | CN1192904A Composite preparation for treatment of dementia |
| 09/15/1998 | US5807900 Method for identifying compounds having increased activity for the repair of skin photodamage |
| 09/15/1998 | US5807884 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 09/15/1998 | US5807834 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| 09/15/1998 | US5807833 Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device |
| 09/15/1998 | US5807831 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 09/15/1998 | US5807689 Bioanalysis |
| 09/11/1998 | WO1998039659A1 Screening and treatment using complement regulator or receptor proteins |
| 09/11/1998 | WO1998039487A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
| 09/11/1998 | WO1998039441A1 Human chemokine receptor-like chemokine |